BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18564355)

  • 41. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
    Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
    Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
    Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
    Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorescent resonance energy transfer (FRET) based detection of a multiplex ligation-dependent probe amplification assay (MLPA) product.
    Ozalp VC; Nygren AO; O'Sullivan CK
    Mol Biosyst; 2008 Sep; 4(9):950-4. PubMed ID: 18704233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization.
    Avet-Loiseau H; Devilder MC; Garand R; Bouyge I; Rapp MJ; Milpied N; Harousseau JL; Moisan JP; Bataille R
    Clin Cancer Res; 1996 Oct; 2(10):1673-7. PubMed ID: 9816115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine.
    Cejkova S; Rocnova L; Potesil D; Smardova J; Novakova V; Chumchalova J; Zezulkova D; Borsky M; Doubek M; Brychtova Y; Pospisilova S; Klabusay M; Mayer J; Trbusek M
    Eur J Haematol; 2009 Feb; 82(2):133-42. PubMed ID: 19018867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
    Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
    Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
    Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
    Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH).
    Alhourani E; Rincic M; Othman MA; Pohle B; Schlie C; Glaser A; Liehr T
    Mol Cytogenet; 2014; 7(1):79. PubMed ID: 25435911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large genomic mutations within the ATM gene detected by MLPA, including a duplication of 41 kb from exon 4 to 20.
    Cavalieri S; Funaro A; Pappi P; Migone N; Gatti RA; Brusco A
    Ann Hum Genet; 2008 Jan; 72(Pt 1):10-8. PubMed ID: 17910737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trisomy 12 in B-cell chronic lymphocytic leukemia: interphase study by in situ hybridization in 75 patients.
    Coignet L; Berthéas MF; Vasselon C; Jaubert J; Reynaud J; Calmard-Oriol P; Brizard CP; Guyotat D
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):129-34. PubMed ID: 8332448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection, analysis and clinical validation of chromosomal aberrations by multiplex ligation-dependent probe amplification in chronic leukemia.
    Abdool A; Donahue AC; Wohlgemuth JG; Yeh CH
    PLoS One; 2010 Oct; 5(10):e15407. PubMed ID: 21049055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene dosage effects in chronic lymphocytic leukemia.
    Sellmann L; Scholtysik R; Kreuz M; Cyrull S; Tiacci E; Stanelle J; Carpinteiro A; Nückel H; Boes T; Gesk S; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
    Cancer Genet Cytogenet; 2010 Dec; 203(2):149-60. PubMed ID: 21156227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of multiplex ligation-dependent probe amplification for confirmation of array comparative genomic hybridization.
    Jennings LJ; Yu M; Fitzpatrick C; Smith FA
    Diagn Mol Pathol; 2011 Sep; 20(3):166-74. PubMed ID: 21817904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Genetic analysis of chorionic villi specimen in spontaneous abortion using various methods].
    Lei Q; Wang Q; Zhou CQ; Chen BJ; Chen Z; Xu YW; Zeng YH
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):253-6. PubMed ID: 19570460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients.
    Eid OM; Abdel Kader RMA; Fathalla LA; Abdelrahman AH; Rabea A; Mahrous R; Eid MM
    J Genet Eng Biotechnol; 2021 Jun; 19(1):98. PubMed ID: 34181122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of fluorescence in situ hybridization value in detection of chronic lymphocytic leukemia].
    Wu W; Gu J; Ma L; Wang H; Ni J; Ji W; Shen LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1095-8. PubMed ID: 23114126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing two diagnostic laboratory tests for Williams syndrome: fluorescent in situ hybridization versus multiplex ligation-dependent probe amplification.
    van Hagen JM; Eussen HJ; van Schooten R; van Der Geest JN; Lagers-van Haselen GC; Wouters CH; De Zeeuw CI; Gille JJ
    Genet Test; 2007; 11(3):321-7. PubMed ID: 17949295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.
    Cosialls AM; Santidrián AF; Coll-Mulet L; Iglesias-Serret D; González-Gironès DM; Pérez-Perarnau A; Rubio-Patiño C; González-Barca E; Alonso E; Pons G; Gil J
    Epigenomics; 2012 Oct; 4(5):491-501. PubMed ID: 23130831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.